The global gene editing market was valued at USD 5.87 billion in 2025 and is anticipated to reach USD 18.55 billion by 2033, expanding at a compound annual growth rate (CAGR) of 15.71% from 2026 to 2033. This notable expansion is being driven by the increasing adoption of advanced gene therapies, a steady rise in investments across biopharmaceutical research, and a growing preference...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt